CoChat

Glycemic Control in Patients With Type 2 Diabetes Mellitus With a Disease‐Specific Enteral Formula: Stage II of a Randomized, Controlled Multicenter Trial

Pohl, Marcus, Mayr, Peter, Mertl‐Roetzer, Marion, Lauster, Frank, Haslbeck, Manfred, Hipper, Beate, Steube, Diethard, Tietjen, Monika, Eriksen, Jan, Rahlfs, Volker W. · 2009 · Journal of Parenteral and Enteral Nutrition
Cited by 51

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Background: Stage I of a preplanned 2‐stage study has provided good evidence for improved glycemic control with a disease‐specific enteral formula low in carbohydrates and high in monounsaturated fatty acids (MUFAs), fish oil, chromium, and antioxidants in insulin‐treated type 2 diabetes. The study was continued with stage II to give confirmatory proof of these beneficial effects. Methods: 105 patients with HbA 1C ≥ 7.0% and/or fasting blood glucose (FG) > 6.7 mmol/L (>120 mg/dL) requiring enteral tube feeding due to neurological dysphagia received 113 kJ (27 kcal)/kg body weight of either test formula (Diben) or an isoenergetic, isonitrogenous standard formula (control) for up to 84 days. Total insulin (TI) requirements, FG, and afternoon blood glucose (AG) were assessed daily. HbA 1C and safety criteria were evaluated on days 1, 28, 56, and 84. Results: 55 patients completed the study; on day 84, median changes from baseline (data as available, test vs control) were the following: TI,– 8.0 vs +2.0 IU; FG, –2.17 vs –0.67 mmol/L (–39.0 vs– 12.1 mg/dL); HbA 1C, –1.30% vs –1.20%; AG,– 2.36 vs –0.49 mmol/L (–42.5 vs –8.9 mg/dL). The number of relevant hypoglycemic episodes (FG < 3.33 mmol/L < 60 mg/dL) was 1 vs 5. Feeding tolerance was comparable in both groups. Conclusions: Long‐term tube feeding with a disease‐specific enteral formula was safe and well tolerated in type 2 diabetic patients with neurological disorders. When compared with a standard diet, TI requirement decreased significantly with less hypoglycemia whereas FG and AG were significantly lowered, resulting in improved glycemic control.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/0148607108324582

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 51

Metadata

Authors
Pohl, M., Mayr, P., Mertl‐Roetzer, M., Lauster, F., Haslbeck, M., Hipper, B., Steube, D., Tietjen, M., Eriksen, J., & Rahlfs, V. W.
Venue
Journal of Parenteral and Enteral Nutrition
Publisher
Wiley
Published
2008-10-02
Volume
33
Issue
1
Pages
37-49
ISSN
  • 0148-6071 (ISSN-L)
  • 1941-2444
OpenAlex
W2026554695
Cited by
51
References
6
FWCI
1.34
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Glycemic Control in Patients With Type 2 Diabetes Mellitus With a Disease‐Specific Enteral Formula: Stage II of a Randomized, Controlled Multicenter Trial. https://app.cochat.ai/papers/10.1177/0148607108324582
The paper
Pohl, M., Mayr, P., Mertl‐Roetzer, M., Lauster, F., Haslbeck, M., Hipper, B., Steube, D., Tietjen, M., Eriksen, J., & Rahlfs, V. W. (2009). Glycemic Control in Patients With Type 2 Diabetes Mellitus With a Disease‐Specific Enteral Formula: Stage II of a Randomized, Controlled Multicenter Trial. Journal of Parenteral and Enteral Nutrition. https://doi.org/10.1177/0148607108324582

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.